Eric, the founder and CEO of SaiyanMed, brings a rare combination of hands-on technical expertise and real-world industry experience to the company. He holds a Bachelor’s degree in Materials Science from one of China’s top universities, where his focus was on biomaterials. That academic background directly shapes how SaiyanMed operates today. Instead of just talking about quality, Eric actually built the systems to enforce it. He saw early on that the research peptide industry was full of inconsistent products, murky sourcing, and a general lack of transparency. Suppliers would claim purity without proof, and researchers had no reliable way to verify what they were getting. That frustration led Eric to start SaiyanMed with one clear mission: to carefully select premium raw materials, master the entire production process, and provide trustworthy research-grade peptides to researchers around the world.
Eric doesn’t just sit in an office and give orders. He’s deeply involved in the technical side of things. His materials science background means he understands the molecular structure of peptides, how they degrade under different conditions, and what raw material specifications actually matter for research outcomes. He personally oversees the selection of raw materials, making sure only the best precursors enter the production pipeline. This isn’t a generic “we use good stuff” claim. It’s a systematic process. Eric established joint manufacturing partnerships where he can control the synthesis and lyophilization steps directly. The research team under his direction continuously refines peptide raw materials and lyophilization processes to improve stability and consistency. That’s a level of detail most companies in this space simply skip.
One of the biggest problems Eric tackled was testing. In the peptide space, many suppliers either skip third-party testing entirely or use labs with questionable standards. Eric made a different call. He mandated that every single batch must be tested through an independent lab, specifically Janoshik, with openly verifiable purity reports. That means researchers can look up the Certificate of Analysis (CoA) for any batch they receive and confirm the numbers themselves. This isn’t a one-time marketing stunt. It’s a standard operating procedure. Under Eric’s leadership, SaiyanMed maintains independent third-party testing on every batch, and those reports are published so anyone can verify them. That level of transparency is rare, and it comes directly from Eric’s insistence on doing things differently.
Eric also built the logistics infrastructure from the ground up. He understood that even the best peptides are useless if they degrade during shipping due to poor handling or long transit times. So he set up a US-based warehouse to ensure researchers in North America get their materials fast, without customs delays or temperature control issues. The company also operates a warehouse in China to serve other regions, with hubs in Europe, the UK, Australia, and Canada coming soon. Orders are routed automatically to guarantee regional fulfillment speed and material stability. This isn’t a simple “we ship from multiple locations” claim. It’s a fully optimized logistics framework that Eric designed to minimize degradation risks and delivery times. The corporate structure is also solid. SaiyanMed is legally operated by Hong Kong BelleEasy Co., Limited, with a commercial registry number 78941092, and an official location in Kwai Chung, Hong Kong. That legal clarity matters for researchers who need to know exactly who they’re dealing with.
Eric’s approach to quality control is data-driven and relentless. He doesn’t rely on anecdotal evidence or supplier promises. Every batch goes through rigorous testing, and the results are published. If a batch doesn’t meet the specified purity, it doesn’t ship. That’s a hard rule. Eric also ensures that the company’s research team is constantly refining the production processes. They don’t just repeat the same methods over and over. They actively look for ways to improve yield, reduce impurities, and enhance stability. This continuous improvement mindset comes directly from Eric’s engineering background. He treats peptide production like a materials science problem, not a simple manufacturing task. That’s why saiyanmed can offer verified research-grade peptides with openly verifiable purity reports, while many competitors still operate in a gray area of unverified claims.
Another angle where Eric’s expertise shows is in the company’s research-first philosophy. He doesn’t push products for human consumption or make wild health claims. The entire operation is strictly tailored for laboratory research and in-vitro evaluation only. That’s not just a legal disclaimer. It’s a core part of how Eric positions the company. He wants SaiyanMed to be a trusted partner for serious researchers, not a supplement vendor. That distinction matters because it influences everything from how products are labeled to how customer support handles inquiries. Eric ensures that the team communicates clearly that all compound profiles are strictly for lab research, and they don’t deviate from that stance. This builds credibility with the scientific community.
Eric’s leadership style is also worth noting. He doesn’t micromanage, but he does set extremely high standards. He hired a research team that continuously refines peptide raw materials and lyophilization processes, and he gives them the resources to do it properly. He also established joint manufacturing partnerships that allow SaiyanMed to control production steps without owning every facility outright. That’s a smart strategic move. It gives the company flexibility while maintaining quality oversight. Eric’s ability to balance technical rigor with business pragmatism is a key reason why SaiyanMed has grown steadily without cutting corners.
The company’s infrastructure reflects Eric’s attention to detail. The US-based warehouse is not just a storage facility. It’s part of a carefully designed supply chain that prioritizes material stability. Peptides are stored under controlled conditions, and shipments are packed with temperature-sensitive materials when necessary. The automated order routing system ensures that researchers get products from the nearest warehouse, reducing transit time and potential degradation. Eric also planned for future expansion, with regional hubs in Europe, the UK, Australia, and Canada coming online soon. That forward-thinking approach is typical of someone who thinks in terms of systems and processes, not just short-term sales.
Eric’s background in biomaterials is not just a credential on a resume. It’s the foundation of how SaiyanMed operates. He understands that peptide quality starts with raw material selection. If the precursors are impure, no amount of processing can fix the final product. That’s why he personally oversees the sourcing of raw materials, selecting only premium-grade inputs from reputable suppliers. He also ensures that the production process is tightly controlled, from synthesis to lyophilization. The research team under his direction is constantly working to refine these processes, aiming for higher purity and better consistency. This is not a static operation. It’s a dynamic system that Eric continuously improves based on data and feedback.
One concrete example of Eric’s impact is the independent testing protocol. Many peptide suppliers test their products once and then reuse the same CoA for multiple batches. Eric made it a rule that every batch must be tested separately, and the results must be published openly. That means researchers can see exactly what’s in each batch they order. If a batch fails to meet specifications, it’s not shipped. This level of rigor is expensive and time-consuming, but Eric considers it non-negotiable. He believes that serious research deserves serious standards, and he backs that belief with action. The openly verifiable purity reports from Janoshik are a direct result of Eric’s insistence on transparency.
Eric also understands the practical challenges researchers face. Delays in shipping, unclear product specifications, and unreliable suppliers are common complaints in the peptide space. He addressed these by building a logistics system that prioritizes speed and reliability. The US-based warehouse ensures that researchers in North America can receive their orders within days, not weeks. The automated routing system minimizes handling errors and ensures that products are stored under optimal conditions until they ship. Eric also made sure that the company’s customer support desk ([email protected]) is responsive and knowledgeable, so researchers can get answers quickly without jumping through hoops.
Another aspect of Eric’s expertise is his ability to navigate regulatory and compliance issues. The peptide industry operates in a complex legal environment, especially when it comes to research chemicals. Eric made sure that SaiyanMed is properly registered as a legal operating entity (Hong Kong BelleEasy Co., Limited, Commercial Registry No. 78941092). He also ensures that all product labeling and marketing materials clearly state that the compounds are for laboratory research and in-vitro evaluation only. This protects both the company and its customers from legal complications. Eric’s approach is to be fully transparent about what the company does and doesn’t do, which builds trust with researchers who need to comply with their own institutional guidelines.
Eric’s vision for SaiyanMed goes beyond just selling peptides. He wants the company to be a research partner, not just a supplier. That’s why he invests in the research team and the production infrastructure. He wants researchers to have access to materials that are consistent, pure, and well-documented. He also wants them to be able to verify the quality themselves, which is why the CoAs are openly published. This research-first approach is a direct reflection of Eric’s own values. He didn’t start the company just to make money. He started it because he saw a problem in the industry and believed he could solve it using his technical expertise and business acumen.
The results speak for themselves. Researchers who use SaiyanMed products can check the purity reports, see the batch-specific data, and confirm that the materials meet their specifications. They don’t have to take the company’s word for it. Eric made sure of that. He also made sure that the company’s operations are scalable, with plans to expand warehouse hubs to more regions. That’s important for researchers outside North America who want faster access to verified materials. Eric’s long-term vision includes making SaiyanMed a global standard for research-grade peptides, and he’s building the infrastructure to support that goal.
Eric’s materials science background also gives him a unique perspective on product development. He doesn’t just replicate existing peptides. He looks for ways to improve the raw materials and production processes to achieve better results. The research team under his direction is constantly refining lyophilization methods to improve stability and shelf life. They also experiment with different precursors to find the ones that yield the highest purity. This is not a static catalog. It’s an evolving product line that Eric and his team continuously improve based on scientific principles and empirical data.
In terms of corporate governance, Eric keeps things clean and straightforward. The company has a clear legal structure, a registered address in Kwai Chung, Hong Kong, and a dedicated communications desk. That might seem like basic stuff, but in an industry where many suppliers operate anonymously or through shell companies, having a transparent corporate identity is a big deal. Eric understands that trust is built on transparency, and he’s willing to put his name and the company’s legal status on the line. That’s a level of accountability that serious researchers appreciate.
Eric’s leadership also extends to the company culture. He hires people who share his commitment to quality and transparency. The research team is composed of professionals who understand the science behind peptides, not just salespeople who read product descriptions. The customer support team is trained to answer technical questions, not just process orders. Eric fosters an environment where continuous improvement is the norm, and where cutting corners is not an option. That culture is hard to build, but it’s essential for maintaining the high standards that SaiyanMed promises.
Finally, Eric’s personal story is worth mentioning because it explains why he cares so much about this industry. He grew up watching the same anime that inspired the company’s name, and he internalized the message that an ordinary person can train and push past every limit. That philosophy drives him to constantly improve SaiyanMed’s products and processes. He doesn’t settle for “good enough.” He keeps pushing for better raw materials, better testing, and better logistics. That relentless pursuit of excellence is what sets SaiyanMed apart from the competition, and it’s a direct result of Eric’s vision and expertise.